The CDK inhibitors in cancer research and therapy Jonas CicenasMindaugas Valius Review 30 August 2011 Pages: 1409 - 1418
Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer Nian-Feng SunQing-Yi MengLi Xu Original Paper 02 August 2011 Pages: 1419 - 1424
Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro Engin UlukayaFerda AriVeysel T. Yilmaz Original Paper 02 August 2011 Pages: 1425 - 1434
Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy Vino T. CheriyanCessal ThomasPrabha Balaram Original Paper 02 August 2011 Pages: 1435 - 1444
An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma Jian-Wen ChengYing-Hong ShiJian Zhou Original Paper 02 August 2011 Pages: 1445 - 1453
A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency Na LiYuanyuan ChuCongjian Xu Original Paper 02 August 2011 Pages: 1455 - 1461
Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls Da-Peng DingYing ZhangWen-Ling Zheng Original Paper 02 August 2011 Pages: 1463 - 1468
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer Shigeki UmemuraHiromichi YamaneHaruhito Kamei Original Paper 05 August 2011 Pages: 1469 - 1475
The hOGG1 gene 5′-UTR variant c.−53G>C contributes to the risk of gastric cancer but not colorectal cancer in the Chinese population Xiufang LiuNong XiaoYaping Wang Original Paper 06 August 2011 Pages: 1477 - 1485
Down-regulation of TWIST decreases migration and invasion of laryngeal carcinoma Hep-2 cells by regulating the E-cadherin, N-cadherin expression Liang YuHui-zheng LiWei Xu Original Paper 07 August 2011 Pages: 1487 - 1493
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome R. F. Falkenstern-GeM. KimmichM. Kohlhaeufl Original Paper 09 August 2011 Pages: 1495 - 1498
Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer Tomomi YakabeHirokazu NoshiroSeiji Satoh Original Paper 10 August 2011 Pages: 1499 - 1504
Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer Jiannan WuShunrong LiFengxi Su Original Paper 10 August 2011 Pages: 1505 - 1510
Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway Mahmoud AghaeiMojtaba PanjehpourSiamak Salami Original Paper 10 August 2011 Pages: 1511 - 1523
Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance Bin-Quan WangChun-Ming ZhangPing-Chang Yang Original Paper 11 August 2011 Pages: 1525 - 1533
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation Yusuf BaranJacek BielawskiBesim Ogretmen Original Paper 11 August 2011 Pages: 1535 - 1544
Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma Ying JinXin AnYan Xia Shi Original Paper 13 August 2011 Pages: 1545 - 1551
GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis Jiawei ChenQiang CaoChangjun Yin Original Paper 13 August 2011 Pages: 1553 - 1561
Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS Lingyun WuXiao LiQuan Pu Original Paper 04 August 2011 Pages: 1563 - 1569
Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers Jin C. KimHan C. LeeYong S. Kim Original Paper 18 August 2011 Pages: 1571 - 1580
Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice Jillian RichmondMichael FinkelWilliam Cruikshank Rapid Communication 05 August 2011 Pages: 1581 - 1585